A study on self-reported outcomes of breast cancer patients infected with SARS-CoV-2 in Beijing during the COVID-19 pandemic
BAI Lixiao
LI Jiayi
WANG Xiaobo
DONG Yinping
LI Liangying
YANG Ailing
Abstract:Objective To investigate breast cancer patients who sought medical care at a single hospitals in Beijing during the COVID-19 pandemic,and to understand their self-reported COVID-19 symptoms and potential related factors.The goal is to provide insights and references for how breast cancer patients can cope with potential re-infection of the COVID-19 virus in the post-pandemic era.Methods A self-designed questionnaire was used to collect 538 breast cancer patients who sought medical care at a certain 3A-grade hospitala in Beijing from December 28,2022 to January 6,2023.The clinical manifestations and possible related factors of breast cancer patients infected with novel coronavirus were investigated to describe the COVID-19 symptoms of breast cancer patients during the"influenza-like"period of the COVID-19 pandemic.Results There were 432 cases(80.3%)reported COVID-19 symptoms among 538 breast cancer patients,of which 357 cases(86.8%)were fever,followed by 279 cases(64.6%)of cough/expectoration,271 cases(62.7%)of fatigue,246 cases(56.9%)of dry throat/sore throat/itchy throat,234 cases(54.2%)of muscle/joint pain,212 cases(49.07%)of dizziness/headache,209 cases(48.38%)of anorexia,196 cases(45.37%)of nasal congestion and runny nose.The first symptom was mainly fever in 248 cases(57.4%).Among 538 breast cancer patients in this survey,273 patients had recurrence and metastasis,accounting for 50.74%,and 204 people recieved COVID-19 vaccination,accounting for 37.92%.Conclusion The self-reported symptoms of breast cancer patients infected with COVID-19 are mainly fever,cough,fatigue,muscle joint pain,dizziness,etc.
Keywords:breast cancerSARS-CoV-2self-report the outcome
Publication Date:2023-10-28
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:5( 445-449 )
